Cases & Deals

JumpStart invests in CerviLenz

Clients JumpStart Inc.

Jones Day counseled JumpStart Inc. in its investment in CerviLenz, Inc., a manufacturer and marketer of a patented, FDA-cleared device to predict preterm birth risk in pregnant women.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.